Tributary Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-19,800
| Closed | -$655K | – | 204 |
|
|
2022
Q1 | $655K | Buy |
19,800
+300
| +2% | +$9.92K | 0.05% | 165 |
|
|
2021
Q4 | $830K | Buy |
19,500
+9,500
| +95% | +$404K | 0.06% | 154 |
|
|
2021
Q3 | $443K | Buy |
+10,000
| New | +$443K | 0.03% | 199 |
|
|
2021
Q2 | – | Sell |
-15,300
| Closed | -$1.15M | – | 232 |
|
|
2021
Q1 | $1.15M | Buy |
+15,300
| New | +$1.15M | 0.09% | 139 |
|